The deletion of the FOXA1 plexus CREs also significantly reduced prostate cancer cell proliferation at levels comparable to what has been reported upon deletion of the amplified CRE upstream of the AR gene in mCRPC55, suggestive of onco-CREs as reported in lung54, and prostate55 cancer. Here, FOXA1 is linked to prostate cancer.